Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03).

about

The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future.

P2860

Q33705268-C61942A9-0DCE-4CFD-9B3E-9E806D73F582

P2860

Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03).

Item

http://www.wikidata.org/entity/Q36965629

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Combined sunitinib and radiati ...... inary sarcoma group (GISG-03).

@en

type

Item

label

Combined sunitinib and radiati ...... inary sarcoma group (GISG-03).

@en

prefLabel

Combined sunitinib and radiati ...... inary sarcoma group (GISG-03).

@en

P1476

Combined sunitinib and radiati ...... inary sarcoma group (GISG-03).

@en

P2093

Anna Simeonova

http://www.w3.org/2001/XMLSchema#string

Bernd Kasper

http://www.w3.org/2001/XMLSchema#string

Frederik Wenz

http://www.w3.org/2001/XMLSchema#string

Geraldine Rauch

http://www.w3.org/2001/XMLSchema#string

Jens Jakob

http://www.w3.org/2001/XMLSchema#string

Peter Hohenberger

http://www.w3.org/2001/XMLSchema#string

Ulrich Ronellenfitsch

http://www.w3.org/2001/XMLSchema#string

P2860

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets.

Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?

Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma.

Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity.

Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas.

Soft tissue sarcoma, version 2.2014.

A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma.

Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.

Phase I trial of concurrent sunitinib and radiation therapy as preoperative treatment for soft tissue sarcoma

P2888

s13014-016-0654-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13014-016-0654-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1025589332

http://www.w3.org/2001/XMLSchema#string

P698

27255678

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

P932

4891890

http://www.w3.org/2001/XMLSchema#string

Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03).

about

P2860

P2860

Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P6179

P698

P921

P932